Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells

被引:0
|
作者
Yanli Bi
Longyuan Gong
Pengyuan Liu
Xiufang Xiong
Yongchao Zhao
机构
[1] Zhejiang University School of Medicine,Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital
[2] Zhejiang University School of Medicine,Zhejiang Provincial Key Laboratory of Pancreatic Disease, the First Affiliated Hospital
[3] Zhejiang University School of Medicine,Institute of Translational Medicine
[4] Zhejiang University School of Medicine,Cancer Institute of the Second Affiliated Hospital
[5] Cancer Center,undefined
[6] Zhejiang University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
ErbB2, a classical receptor tyrosine kinase, is frequently overexpressed in breast cancer cells. Although the role of ErbB2 in the transmission of extracellular signals to intracellular matrix has been widely studied, the functions of nuclear ErbB2 remain largely elusive. Here, we report a novel function of nuclear ErbB2 in repressing the transcription of DEPTOR, a direct inhibitor of mTOR. Nuclear ErbB2 directly binds to the consensus binding sequence in the DEPTOR promoter to repress its transcription. The kinase activity of ErbB2 is required for its nuclear translocation and transcriptional repression of DEPTOR. Moreover, the repressed DEPTOR by nuclear ErbB2 inhibits the induction of autophagy by activating mTORC1. Thus, our study reveals a novel mechanism for autophagy regulation by functional ErbB2, which translocates to the nucleus and acts as a transcriptional regulator to suppress DEPTOR transcription, leading to activation of the PI3K/AKT/mTOR pathway to inhibit autophagy.
引用
收藏
相关论文
共 50 条
  • [41] MET and ERBB2 Are Coexpressed in ERBB2+ Breast Cancer and Contribute to Innate Resistance
    Paulson, Amanda K.
    Linklater, Erik S.
    Berghuis, Bree D.
    App, Colleen A.
    Oostendorp, Leon D.
    Paulson, Jayne E.
    Pettinga, Jane E.
    Melnik, Marianne K.
    Woude, George F. Vande
    Graveel, Carrie R.
    MOLECULAR CANCER RESEARCH, 2013, 11 (09) : 1112 - 1121
  • [42] Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
    Eya Wolfson
    Shira Solomon
    Eran Schmukler
    Yona Goldshmit
    Ronit Pinkas-Kramarski
    Cell Death & Disease, 9
  • [43] Aberrations of ERBB2 and TOP2A genes in breast cancer
    Nielsen, Kirsten Vang
    Muller, Sven
    Moller, Susanne
    Schonau, Andreas
    Balslev, Eva
    Knoop, Ann S.
    Ejlertsen, Bent
    MOLECULAR ONCOLOGY, 2010, 4 (02) : 161 - 168
  • [44] Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
    Wolfson, Eya
    Solomon, Shira
    Schmukler, Eran
    Goldshmit, Yona
    Pinkas-Kramarski, Ronit
    CELL DEATH & DISEASE, 2018, 9
  • [45] Clinical and genomic landscape of ERBB2 and ERBB3 mutated breast cancer
    Bilani, Nadeem
    Tao, Jacqueline
    Safonov, Anton
    Casey, Dana
    Drago, Joshua
    Ahmed, Mehnaj
    Acevedo, Barbara
    Jhaveri, Komal
    Reis-Filho, Jorge
    Robson, Mark
    Toska, Eneda
    Hanker, Ariella
    Arteaga, Carlos
    Chandarlapaty, Sarat
    Wen, Hanna Y.
    Razavi, Pedram
    CANCER RESEARCH, 2024, 84 (09)
  • [46] Dual targeting of ErbB1 and ErbB2 enhances response to chemotherapy in ErbB2 overexpressing breast cancer cell lines.
    O'Donovan, N.
    Clynes, M.
    Crown, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S105 - S105
  • [47] Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells
    Canfield, Kaleigh
    Li, Jiaqi
    Wilkins, Owen M.
    Morrison, Meghan M.
    Ung, Matthew
    Wells, Wendy
    Williams, Charlotte R.
    Liby, Karen T.
    Vullhorst, Detlef
    Buonanno, Andres
    Hu, Huizhong
    Schiff, Rachel
    Cook, Rebecca S.
    Kurokawa, Manabu
    CELL CYCLE, 2015, 14 (04) : 648 - 655
  • [48] The role of ErbB2 in regulating survival in matrix-detached inflammatory breast cancer cells
    Buchheit, Cassandra L.
    Angarola, Brittany
    Steiner, Allison
    Schafer, Zachary
    CANCER RESEARCH, 2012, 72
  • [50] Ethanol Enhances the Interaction of Breast Cancer Cells Over-Expressing ErbB2 With Fibronectin
    Xu, Mei
    Bower, Kimberly A.
    Chen, Gang
    Shi, Xianglin
    Dong, Zheng
    Ke, Zunji
    Luo, Jia
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (05) : 751 - 760